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See page 537 for the editorial comment on this articleBackground The use of ultrathin Doppler angioplasty guidewires has made it possible
to measure collateral flow quantitatively. Pharmacologic interventions have been
shown to influence collateral flow and, thus, to affect myocardial ischaemia.
Methods Twenty-five patients with coronary artery disease undergoing PTCA were
included in the present analysis. Coronary flow velocities were measured in the ip-
silateral (n ¼ 25) and contralateral (n ¼ 6; two Doppler wires) vessels during PTCA
with and without i.v. adenosine (140 lg/kg.min) before and 3 min after 5 mg
metoprolol i.v., respectively. The ipsilateral Doppler wire was positioned distal to the
stenosis, whereas the distal end of the contralateral wire was in an angiographically
normal vessel. The flow signals of the ipsilateral wire were used to calculate the
collateral flow index (CFI). CFI was defined as the ratio of flow velocity during balloon
inflation divided by resting flow.
Results Heart rate and mean aortic pressure decreased slightly (ns) after i.v. meto-
prolol. The collateral flow index was 0.25 0.12 (one fourth of the resting coronary
flow) during the first PTCA and 0.27 0.14 (ns versus first PTCA) during the second
PTCA, but decreased with metoprolol to 0.16 0.08 (p < 0:0001 vs. baseline) during
the third PTCA.
Conclusions Coronary collateral flow increased slightly but not significantly during
maximal vasodilatation with adenosine but decreased in 23 of 25 patients after i.v.
metoprolol. Thus, there is a reduction in coronary collateral flow with metoprolol,
probably due to an increase in coronary collateral resistance or a reduction in oxygen
demand.c 2004 Published by Elsevier Ltd on behalf of The European Society of Cardiology.
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Coronary collateral circulation is an important patho-
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doi:10.1016/j.ehj.2004.02.003area jeopardised by an occluded or stenotic artery. The
functional relevance of coronary collaterals in humans has
been a matter of debate for many years.1–3 Previous
studies have demonstrated a protective role of collaterals
in patients with coronary artery disease, which show a
smaller infarct size,4 less ventricular aneurysm forma-
tion, improved ventricular function,4;5 and better sur-
vival6 compared to patients without collaterals. Much of
the controversy about collaterals is due to inadequatebehalf of The European Society of Cardiology.
CAD Coronary artery disease
CFI Collateral flow index
ic Intracoronary
PTCA Percutaneous transluminal coronary angio-
plasty
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566 M. Billinger et al.methods to determine collateral blood flow. Semiquanti-
tative (angiographic) methods have been used to estimate
the extent of coronary collaterals1 or acutely recruitable
collaterals during angioplasty.7;8 Intracoronary Doppler
wires have been used to measure flow velocity in patients
with coronary stenosis9–11 and collaterals.12–15 The theo-
retical basis for the use of intracoronary flow velocity
measurements to determine collateral flow relates to the
fact that velocity signals distal to an occluded stenosis
almost invariably originate from collaterals.
Physical exercise, mental stress, and drugs influence
collateral flow. The effect of cardioselective b-blockers
such as metoprolol has not yet been studied, although
this class of drugs favourably influences the occurrence
of myocardial ischaemia by reducing myocardial oxygen
consumption. On the other hand, b-blockers increase
coronary vascular resistance16 and thus may diminish
collateral perfusion, aggravating myocardial ischaemia.
Thus, the purpose of the present study was to assess
coronary collateral flow before and after adenosine in-
fusion and with and without intravenous b-blockade.Table 1
n %
Number of patients 25 –
Age (years) 58 10 –
Men 24 96
Cardiovascular risk factors
Smoking 11 44
Diabetes mellitus 4 16
Family history of CAD 6 24
Obesity 3 12
Hypertension 11 44
Hypercholesterolemia 6 24
Medication
Aspirin 21 84
b-Blockers 0 0
Calcium antagonists 3 12
Lipid lowering agents 4 16Methods
Patients
Twenty-fivepatients (age58 10 years, allmen)withone- or two-
vessel diseasewere included in thepresentanalysis (Table 1). Five
of the 25 patients had previous myocardial infarction in the non-
PTCA perfusion territory and none of these patients had a Q-wave
infarct. All patients underwent percutaneous transluminal coro-
nary angioplasty (PTCA) for clinical motives (angina pectoris or
positive exercise test with ST-segment depression). The percent
diameter stenosis of the dilated vessel was 83 10% before and
6 8% after the intervention. Cardiovascular risk factors and
preintervention medication are summarised in Table 1.
Inclusion criteria: Patients with coronary artery disease and
angina pectoris, age 18–80 years, indication for PTCA, written
informed consent, and absence of allergy to adenosine or
metoprolol.
Exclusion criteria: Unstable angina pectoris and myocardial
infarction (<2 months), hypertension with left ventricular hy-
pertrophy, tortuous coronary arteries, women of childbearing
age, or b-blocker treatment.
This investigation was approved by the local ethics
committee.ACE inhibitors 7 28
Nitrates 8 32
Vessel studied
LAD/LCX/RCA 12/5/8 48/20/32
% Diameter stenosis
Pre-PTCA (%) 83 10
Post PTCA (%) 6 8Power calculation
The appropriate sample size for the present study was assessed
by power analysis. A decrease in collateral flow index from 0.25
to 0.20 after metoprolol would require a sample size of 10 pa-
tients (assuming a standard deviation of the difference betweenthe two CFI values of 0.05; power: 80%; p < 0:05).15 With 16
patients, a power of 96% would be achieved.
Coronary angiography
Patients underwent left heart catheterisation for diagnostic
purposes. Aortic pressure was measured using the PTCA guiding
catheter. Biplane left ventricular angiography was performed
followed by diagnostic coronary angiography. Coronary artery
lesions were estimated quantitatively as percent diameter re-
duction. Coronary collateral flow was assessed by the Rentrop
score.8
Doppler flow velocity measurements
Doppler flow velocity measurements were performed using a
0.014 inch (1/3 mm in diameter) PTCA Doppler guidewire with a
12-MHz piezoelectric crystal at its tip (FloWire, EndoSonics,
Rancho Cordova, California, USA). The validation of this Doppler
guidewire has been described previously.10
The collateral flow index (CFI) was determined as the ratio of
the flow velocity time integral distal to the occluded artery
during balloon dilatation divided by baseline flow velocity ob-
tained at the same location prior to PTCA (Fig. 1).15 In a sub-
group of 6 patients, contralateral and ipsilateral flow velocity
was measured in a normal (contralateral) and a “stenotic”
(ipsilateral) vessel segment. A peripheral vein was used for fluid
application and adenosine infusion.
Fig. 1 Representative recordings of a flow velocity signal in a patient
with single vessel disease undergoing PTCA. From left to right, the flow
signal is shown at rest, during balloon occlusion, and after balloon de-
flation with postischaemic hyperaemia. The following tracings are shown
from top to bottom: electrocardiogram (ECG), aortic pressure (aop), in-
stantaneous flow velocity, and flow velocity trend. Please, note that
during balloon occlussion, coronary flow velocity dops from 18 to 6.9 cm/
s but increase after balloon deflation to 53 cm/s. The collateral flow
index for this patients is 0.41.
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After diagnostic coronary angiography, an interval of at least 10
min was allowed for dissipation of the effect of the nonionic
contrast medium (iopamidol 755 mg/300 mg iodium) on coro-
nary flow velocity and vasomotion. An intracoronary (ic) bolus of
0.2 mg of nitroglycerin was given to keep the calibre of the
epicardial coronary artery constant, and thus eliminate dimen-
sional changes in the epicardial vessels that could influence flow
indices. The Doppler guidewire was positioned distal to the
stenosis to be dilated, and coronary flow velocity reserve mea-
surements were obtained. Flow velocity was measured in 12
patients in the left anterior descending, in 5 in the circumflex,
and in 8 in the right coronary artery (Table 1). Collateral flow
velocity was measured continuously during the first balloon oc-
clusion without adenosine (PTCA 1) and during a second occlu-
sion with i.v. adenosine (PTCA 2). Then, 5 mg metoprolol was
administered intravenously over 5 min. After an interval of 5
min, collateral flow velocity was determined during a third
balloon occlusion, at first without and then with i.v. adenosine
(PTCA 3, Fig. 2). Before each balloon inflation, resting flow ve-
locity was determined at the same location as during balloon
occlusion (baseline measurement). Intravenous adenosine infu-
sion was associated with an increase in coronary flow as early as
15–20 s. An intracoronary ECG was recorded from the DopplerFig. 2 Study protocol: Prior to coronary flow measurements, 200 lg nitrogly
balloon inflations (60 s each) are performed (PTCA 1–3). 1st PTCA: Control infl
followed by adenosine infusion during balloon inflation.guidewire and 3 standard ECG leads were recorded. Blood
pressure was measured continuously with the guiding catheter
at the ostium of the coronary artery. During balloon occlusion,
16 of the 25 patients showed ST-segment changes in the intra-
coronary ECG but only half of them had clinical symptoms (an-
ginal pain).
In 6 of the 25 patients a second Doppler wire was introduced
in the contralateral vessel to study flow changes in an angio-
graphically normal vessel segment. Coronary flow velocity was
measured at rest and during PTCA and adenosine infusion in both
the ipsilateral and contralateral vessel segments. The contra-
lateral vessel segment served as a control region for flow
changes during the study protocol.
Statistical analysis
Comparison of angiographic, haemodynamic, and Doppler flow
velocity data was performed by an analysis of variance (ANOVA)
for repeated measurements. Data were analysed at baseline,
after adenosine infusion, and after metoprolol administration.
Only fixed, no random, effects were included. There was one
treatment group. A saturated model was used with different
estimates of the mean, but no assumption was made as to
whether a time point was baseline or a PTCA measurement. The
covariance structure was used to account for the dependence of
coronary collateral flow between different measurements of a
single patient. Regarding the covariance matrix, a check of the
correlation coefficients between the different measurements
indicated that compound symmetry is a reasonable assumption.
In addition to the model-based estimates as given in the man-
uscript, we also calculated empirical standard errors, for which
it has been shown that the results are valid even if the covari-
ance matrix is misspecified. There was no material difference in
the results. Statistical significance was defined as a p-value of
<0:05.Results
Representative flow velocity recordings during and after
balloon inflation are shown in Fig. 1. During balloon oc-
clusion (left panel), flow velocity dropped from 18 to 6.9
cm/s but increased after balloon deflation (¼ postis-
chaemic hyperaemia; middle panel) to 53 cm/s. Aftercerin is administered for maximal vasodilatation. Then three consecutive
ation, 2nd PTCA: Adenosine infusion, 3rd PTCA: Metoprolol administration
Table 3 Flow velocity during baseline, respectively, PTCA
1–3
Flow velocity
(cm/s)
Baseline 1 11.6 4.6
PTCA 1 after 5 s 3.9 1.8
PTCA 1 after 50 s 3.8 1.9
Baseline 2 16.8 5.5
PTCA 2 after 5 s (adenosine) 4.2 2.1
PTCA 2 after 50 s (adenosine) 4.5 2.4
Baseline 3 16.7 4.9
PTCA 3 after 5 s (metoprolol) 3.2 1.7
PTCA 3 after 50 s (metoprolol
and adenosine)
2.5 1.3
Baseline 4 15.8 4.4y
PTCA¼ percutaneous transluminal coronary angioplasty; *p < 0:002
vs. PTCA 1 and 2 after 5 and 50 s and vs. PTCA 3 after 5 s. yp¼NS vs.
baseline 1 and 2.
Fig. 3 Collateral flow index (collateral flow velocity divided by resting
flow velocity). There is a slight, but non-significant, increase in collateral
flow index during adenosine infusion (PTCA 2), but a significant drop
during adenosine infusion after metoprolol administration (PTCA 3).
568 M. Billinger et al.returning to baseline (right panel), the resting flow ve-
locity was 18 cm/s. The collateral flow index for this
patient was 0.41.
Haemodynamics
There was a significant decrease in the rate-pressure
product after metoprolol infusion compared to baseline 1
or PTCA 1. Heart rate and mean aortic pressure de-
creased slightly, although not significantly, after meto-
prolol infusion (Table 2). Collateral assessment according
to Rentrop8 showed good collateral flow (Rentrop 2–3) in
13 patients and poor collateral flow (Rentrop 0–1) in 12
patients. The collateral flow index was 0.30 0.13 in
patients with Rentrop 2–3 and 0.19 0.08 in those with
Rentrop 0–1 (p ¼ 0:01). The response to metoprolol or
adenosine was similar in these 2 groups.
Flow velocity data
Flow velocity decreased significantly during PTCA 1, 2
and 3, respectively. Coronary flow was unchanged be-
tween balloon inflations, i.e., there was no significant
change in coronary flow between baseline 1–4 (Table 3).
Adenosine had only a minor effect on coronary flow ve-
locity during PTCA. However, in 8 patients there was a
mild decrease in coronary flow velocity, which was not
significant when compared to the other patients. After 5
mg intravenous metoprolol, coronary flow velocity de-
creased in 23 of the 25 patients during PTCA. This flow
velocity (PTCA 3) was significantly lower than during
PTCA 1 or 2. Baseline flow velocity remained, however,
unchanged during metoprolol. There were no differences
between vascular beds, i.e., between the left anterior
descending and right coronary artery.
In 6 of the 25 patients, the coronary flow velocity of
the ipsilateral (“stenotic”) and contralateral (normal)
vessel was measured simultaneously. Despite a signifi-
cant increase in the flow velocity of the contralateral
vessel (from 19 7 to 41 9 cm/s), no effect on ipsi-
lateral flow velocity was observed after i.v. adenosine,
but a significant drop in ipsilateral flow velocity (fromTable 2 Hemodynamic variables during baseline, respec-
tively, PTCA 1–3
Heart rate
(min1)
Mean aortic
pressure
(mmHg)
Rate pressure
product (103
mmHg min1)
Baseline 1 74 10 97 13 7.2 1.4
PTCA 1 75 8 96 12 7.2 1.2
Baseline 2 74 10 96 12 7.1 1.3
PTCA 2 75 10 96 11 7.2 1.4
Baseline 3 75 10 96 10 7.2 1.2
PTCA 3
(with metoprolol)
73 9 94 12 6.9 1.3*
Baseline 4 73 10 95 13 6.9 1.4
PTCA¼ percutaneous transluminal coronary angioplasty. *p < 0:02
vs. PTCA 1.3.6 1.9 to 2.5 1.5 cm/s) was found after metoprolol
during pharmacologic hyperaemia (Fig. 4).
Collateral flow index
The collateral flow index was similar during PTCA 1
(0.25 0.20) and 2 (0.27 0.14) with and without
adenosine. However, after metoprolol infusion, adeno-
sine led to a significant fall in collateral flow index
(0.16 0.06), indicating a reduction in coronary collat-
eral flow following i.v. b-blockade (Fig. 3).Discussion
Coronary collateralisation plays an important role in
the pathophysiology of myocardial ischaemia and limits
the size of myocardial infarction in patients with cor-
onary artery disease. Sudden occlusion of the supply
Fig. 4 Flow data from 2 Doppler wires (n ¼ 6): One flow wire is in the
contralateral (normal) and one in the ipsilateral (PTCA) vessel. Please
note that coronary flow velocity increases significantly during adenosine
infusion (contralateral vessel), whereas flow velocity remains unchanged
in the ipsilateral vessel during balloon inflation. Following adenosine in-
fusion (after metoprolol), flow velocity increases only in the contralat-
eral (normal) vessel, but decreases in the ipsilateral (occluded) vessel.
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infarcts than in chronic coronary artery disease be-
cause coronary circulation does not have enough time
to develop collaterals. Coronary collaterals may occur
with repeated ischaemia17 or during exercise training.18
in the presence of a high-grade stenosis However,
collateral flow is dependent on coronary vasomotor
tone and decreases with vasoconstrictor agents or
changes in coronary perfusion pressure. Thus, the
purpose of the present study was to assess coronary
collateral perfusion before and after b-blockade in
patients with coronary artery disease undergoing PTCA
for therapeutic reasons. Collateral flow velocity was
measured with a Doppler wire during balloon inflation
using i.v. adenosine to induce maximal coronary vaso-
dilatation of collateral-dependent and collateral-sup-
plying arteries.
Coronary collateral flow with metoprolol
The coronary collateral flow index increased slightly
during the intravenous administration of adenosine
(Fig. 3) in 13 of 25 patients, but remained unchanged or
even decreased in 12 patients. These changes did,
however, not reach statistical significance. After meto-
prolol, the collateral flow index decreased significantly
when adenosine was given intravenously (Fig. 3). Two
thirds (n ¼ 16) of all patients showed ST-segment chan-
ges in the intracoronary ECG during balloon occlusion.Half of these patients developed anginal pain which was
due to either ischaemia or adenosine-induced chest
discomfort that could not be differentiated. Despite the
fall in collateral flow after metoprolol, during adenosine
infusion no more patients developed anginal pain. This
can be explained either by the small extension of the
ischaemic zone or by the preponderance of the oxygen-
saving mechanism of metoprolol with a significant re-
duction in the rate-pressure product (Table 2). The fall
in collateral flow could be due either to metoprolol di-
rectly (increase in resistance) or due to the decrease in
oxygen requirements (decrease in the rate-pressure
product). Other mechanisms may also have been in-
volved, such as preconditioning of the ischaemic myo-
cardium by repeated balloon inflation or stunning of the
myocardium at risk. Previous experimental and clinical
data have shown that during sympathetic activation
coronary collateral perfusion increases due to the re-
duction in the pressure gradient across the collateral
vessel.19 By analogy, the application of a b-blocker leads
to an increase in coronary collateral resistance. This may
explain why collateral flow velocity decreases after
metoprolol. However, in the daily clinical setting, b-
blockers have been rarely associated with an increase in
symptoms. Therefore, the decrease in coronary collat-
eral flow may be associated with a reduction in myo-
cardial oxygen consumption induced by the decrease in
the rate-pressure product.
In 6 of the 25 patients, the coronary flow velocity of
the ipsilateral (“stenotic”) and contralateral (normal)
vessels was measured simultaneously. Despite a signifi-
cant increase in flow velocity of the contralateral vessel
(from 19 7 to 41 9 cm/s), the collateral flow of the
ipsilateral vessel did not increase during balloon occlu-
sion after i.v. adenosine. In contrast, there was a drop in
ipsilateral flow velocity from 3.6 1.9 to 2.5 1.5 cm/s
after metoprolol during adenosine (Fig. 4). Thus, the
contralateral vessel shows a typical hyperaemic re-
sponse, whereas the ipsilateral occlusive flow velocity
(i.e., collateral flow) decreased after metoprolol in 23 of
the 25 patients.
Thus, the reduction in coronary collateral flow after
metoprolol appears to be due to a vasoconstrictive re-
sponse of the collateral vessel with an increase in vas-
cular resistance.Limitations
Several potential limitations of the present study should
be considered.
(1) The exact mechanism responsible for the reduction
in coronary collateral flow after metoprolol is not
clear but may require adjustment of the heart rate
and blood pressure to keep one of the determinants
of collateral flow constant.
(2) The effect of i.v. metoprolol on heart rate and blood
pressure was relatively modest. This would favour
the hypothesis of a direct effect of metoprolol
on collaterals rather than a secondary decrease in
570 M. Billinger et al.collateral flow due to the decrease in the rate-pres-
sure product.References
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